Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025)
Benitec Biopharma's (BNTC) quarterly Change in Accured Expenses came in at $19000.0 in Q4 2025, up 120.43% year-on-year from $8619.5 in Q4 2024, and down 48.65% quarter-over-quarter from $37000.0 in Q3 2025.
Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma has disclosed Change in Accured Expenses across 7 years of filings, most recently posting $19000.0 for Q4 2025.
- Change in Accured Expenses for Q4 2025 came in at $19000.0, up 120.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $52000.0 (up 161.9% YoY), and the FY2025 annual result was -$81000.0, down 307.69% from the prior year.
- Change in Accured Expenses came in at $19000.0 for Q4 2025 at Benitec Biopharma, down from $37000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $159000.0 in Q1 2025 to a low of -$163000.0 in Q2 2025.
- The 5-year median for Change in Accured Expenses is $17500.0 (2024), against an average of $13150.0.
- Peak annual rise in Change in Accured Expenses reached 7850.0% in 2025, while the deepest fall reached 1711.11% in 2025.
- Benitec Biopharma's Change in Accured Expenses stood at $3000.0 in 2021, then soared by 100.0% to $6000.0 in 2022, then surged by 733.33% to $50000.0 in 2023, then slumped by 286.0% to -$93000.0 in 2024, then jumped by 120.43% to $19000.0 in 2025.
- The last three Change in Accured Expenses figures came in at $19000.0 (Q4 2025), $37000.0 (Q3 2025), and -$163000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Benitec Biopharma | 488.21 Mn | 488.21 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |